Page 17 - HPIC E-Magazine (January-2021)

News from Abroad

SPECIALITY INGREDIENTS
Gattefossé plans new production unit in Texas

French supplier of speciality in-
gredients, Gattefossé, is investing
30-mn in its industrial operations
and will build a new manufacturing
plant in Lufkin, Texas (USA) that pro-
duce lipid based speciality ingredi-
ents for the personal care and pharma
industries. Construction of the new
plant will begin this year and the
plant is expected to deliver its first
customers in 2024.

The group already operates a tech-
nical centre in Paramus, New Jersey,
since 2017. The new manufacturing
plant in Texas will be the company’s
third production location after France
and Singapore. With the new produc-
tion site, the company is seeking to “The opening of a manufacturing cal location of this new site will faci-

deepen its presence in North America, unit represents an essential mile- litate logistics and supply chain.
its main market after France, to stone in our strategy to enhance our Production in Texas is first intended
better meet local customers’ needs, local presence and commitment to to serve the North American market
to increase its global production capa- this important and influential mar- but will gradually be extended to
city, and add a new back-up unit to ket. The ‘Made in USA’ label will other regions,” said Mr. Éric Brun,
its supply portfolio, thus bringing satisfy a strong demand expressed President and CEO, Gattefossé USA
more flexibility to all its customers. by our customers and the geographi- and Canada.
PROJECT UPDATE
France’s Seqens likely to begin supply of IPA from

new unit in 2022

French pharmaceutical and petro- The second unit will add to the and cosmetics applications, as well as
chemicals company Seqens will start company’s existing 70,000-tpa of for disinfectants and hand sanitisers
supplying isopropanol (IPA) from a IPA supplies at the Roussillon site. production.
new unit in the first quarter of 2022, Seqens, a major European player
according to a report by S&P Global in high value oxygenated solvents, This investment will improve the
Platts. will see its global annual production downstream integration, utilising Se-
capacity of IPA increase by around qens’ acetone/phenol production and
The new unit will be based at the 65%, with plans to increase it fur- will boost the offering of IPA grades
Roussillon platform in Isere, southeast ther thereafter. including pharmaceutical, cosmetic,
France, and will have a capacity of technical, electronic and biocide.
45,000-tpa, expandable by up to 20%. Seqens sees demand for IPA and
Construction of the new unit will start derivatives such diisopropyl ether The biocide grade is used for hand
in early 2021 and will be completed (DIPE) and isopropyl acetate (IPAC) sanitisers, demand for which has
within the year, in line with the com- rising in the coming years. The com- soared during the coronavirus pan-
pany’s initial announcement in April pany serves demand for oxygenated demic, which pushed prices to all-
of the increased IPA production plan. solvents used primarily in the pharma time highs earlier in 2020.
Home, Personal & Institutional Care India January 2021 17